After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Most recently, Yahoo Finance reported about the stock as it publicized that N/A.
Stocks Info
As a NYSE listed company, JNJ falls under the Healthcare sector while operating within the Drug Manufacturers – General industry segment. The current market capitalization of Johnson & Johnson is $402.99B. A total of 8.91 million shares were traded on the day, compared to an average of 8.27M shares.
In the most recent transaction, REED JOHN C sold 19,137 shares of JNJ for 163.55 per share on Jul 17 ’25. After the transaction, the EVP, Innovative Medicine, R&D now owns 10,658 company shares. In a previous transaction on Jul 17 ’25, REED JOHN C bought 19,137 shares at 163.55 per share.
Among the insiders who sold shares, Decker Robert J disposed of 6,999 shares on Feb 25 ’25 at a per-share price of $165.88. This resulted in the VP Corporate Controller holding 21,001 shares of JNJ after the transaction. In another insider transaction, Decker Robert J bought 6,999 shares at $165.88 per share on Feb 25 ’25.
Dividend
Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. Johnson & Johnson pays an annual dividend of $5.02, resulting in a dividend yield of 3.00%, and it has a price to earnings (P/E) ratio of 17.90.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, JNJ has a high of $169.99 and a low of $140.68.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. JNJ’s latest balance sheet shows that the firm has $31.61B in Cash & Short Term Investments as of fiscal 2021. There were $33.75B in debt and $45.23B in liabilities at the time. Its Book Value Per Share was $32.60, while its Total Shareholder’s Equity was $74.02B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for JNJ is Buy with a score of 3.92.
